01/16/2008 - Fundamental Applied Biology, Inc. Is Awarded NSF SBIR Phase IIB Grant for the Commercialization of Protein Therapeutics Using Cell-Free Technology

12/10/2007 - Fundamental Applied Biology, Inc. Completes $21 Million Series B Financing. Daniel S. Gold, PhD, Joins as Chief Executive Officer

CONTACT:

Patricia Sinatra
VP, Business Development and Commercial Strategy
Fundamental Applied Biology, Inc.
Phone: (650) 329-9374
psinatra@cellfree.com
www.cellfree.com